In addition, the p53/miR-503-5p/PUMA signaling pathway modulated the CRC chemosensitivity and hypnotized that miR-503-5p regulated the development of CRC by regulating PUMA expression [26, 27]. The gene discussed is TP53; the disease is colorectal carcinoma.